From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Hypertension>
  4. Archives

Hypertension: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 76-100 of 195 are shown

Which Came First — Kidney Dysfunction or Hypertension?

Renal dysfunction could have an etiologic role in essential hypertension, at least in some people.

Should We Treat Hypertension in Very Old People?

In the HYVET, relatively healthy octogenarians benefited from antihypertensive therapy.

Are Antihypertensive Drugs Neuroprotective in Parkinson Disease?

A large case-control study suggests that calcium channel blockers are the only antihypertensives that reduce the risk for Parkinson disease.

Is It Too Late to Have a Drink?

Individuals who began consuming alcohol in middle age had no increased mortality risk and had lower rates of cardiovascular events than did persistent nondrinkers.

Aggressive Treatment of High LDL Levels and Hypertension in Patients with Diabetes

Three-year results from SANDS supply much-needed information but no definitive answer to the question of how low to set targets in primary prevention of CVD.

Effects of Statins and ACE Inhibitors in CAP and Influenza

An analysis of VA data indicates that, at least in men, statin or ACE inhibitor use is associated with decreased mortality from community-acquired pneumonia or influenza.

You’re Never Too Old to Start Treatment for Hypertension

Findings from a randomized trial suggest that antihypertensive therapy lowers risk not only for stroke, but also for death from any cause.

Pioglitazone vs. Glimepiride for Atherosclerosis in Diabetes

Pioglitazone comes out on top in this randomized trial, but we still need outcomes data.

"Do I Have to Take Off My Shirt?"

Reading blood pressure on a sleeved arm might be fine, but one expert urges caution.

High BP in the Emergency Department: Stress or Hypertension?

Patients who are hypertensive in the ED should be advised to get follow-up blood pressure measurements.

Hypertension Vaccine: A New Therapeutic Strategy?

In a phase II study, immunization against angiotensin II lowered blood pressure.

Choice of Antihypertensive Agents for Patients with Metabolic Syndrome: ALLHAT Results

Diuretics should continue to be first-line agents for treating patients with hypertension.

Declining MI and Cardiovascular Risk Factors

The age-adjusted hazard for MI declined by 62% among British men who were followed for 25 years.

Risk Factor Control in Symptomatic Intracranial Stenosis

Rx: Aggressive blood pressure and cholesterol control, and a glass of wine?

Blood Pressure and Risk for Developing Diabetes

Elevated BP as well as BP escalations over time — even if only in the high-normal range — puts women at increased risk for diabetes.

Glucose-Control Arm of ACCORD Trial Halted Early

Increased mortality associated with aggressive glucose reduction raises safety concerns.

Patient Adherence and Treatment Intensification in Hypertension Management

In an observational study, patients whose blood pressure remained persistently elevated were likely to be nonadherent to their therapy.

Predicting the Development of Hypertension

A new tool derived from the Framingham Heart Study targets a modifiable risk factor for heart disease.

Genetic Variance and Hypertension Therapy

An <$EMPH_O>NPPA<$EMPH_C> genotype was associated with differences in treatment response and outcome in patients treated with diuretics versus other drug classes.

Inadequate Blood Pressure Control in U.S. Adults

Patients at risk for cardiovascular events are likely to have high blood pressure, even when treated for hypertension.

Screening for Hypertension

A grade A recommendation calls for blood pressure screening of adults aged 18 and older.

Metabolic Syndrome: Risk Factor for Leukoaraiosis and Age-Related Dementia?

Some facets of metabolic syndrome are related to leukoaraiosis; aggressive treatment of these might reduce risks for stroke and dementia.

Statins and Hemorrhagic Stroke: Shedding Light on SPARCL

A new analysis of influential trial data clarifies the risks associated with statins for secondary prevention of stroke.

Cholesteryl Ester Transfer Protein Inhibition for Dyslipidemia: Hope Remains

An experimental drug shows promise in phase I trials, but many questions still need answers.

Revised Guidelines for Management of Chronic Stable Angina

A focused update of the 2002 ACC/AHA guidelines amends secondary prevention recommendations.

Items 76-100 of 195 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.